Kenneth D'ortone, DPM
Primary Podiatric Medicine · Philadelphia, PANPI 1538173604
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,428 of the $2,370 with a category attached, or 60.3%. DJO, LLC accounts for 61.0% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $1,952, more than ten times the $40 reported in 2019.
Across 36 payments — averaging $65.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$1K
- Averitas Pharma Inc.$175
- Kerecis Limited$169
- Smith+Nephew$115
- Nevro Corp.$99
- Stryker$84
- plus $282 from 9 others
What the payments were for
- Food & beverage$94240%
- Other$1,42860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 2 | $1,446 |
| Averitas Pharma Inc. | 2 | $175 |
| Kerecis Limited | 7 | $169 |
| Smith+Nephew | 6 | $115 |
| Nevro Corp. | 5 | $99 |
| Stryker | 2 | $84 |
| Convatec Inc. | 2 | $81 |
| Paratek Pharmaceuticals, Inc. | 3 | $54 |
| Reapplix Inc. | 1 | $26 |
| Vertex | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $21 |
| Zimmer Biomet | 1 | $21 |
| Paragon 28, Inc. | 1 | $17 |
| Acera Surgical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$151
How this compares
$2,370 in reported general payments places this provider in the 80th percentile of 31 primary podiatric medicine providers in Pennsylvania.
See all primary podiatric medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 42 | $1,517 |
| Ammonium Lactate | 17 | $394 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Philadelphia
- Michael DowneyPhiladelphia$9K
- Ketan KothariPhiladelphia$2K
- Bruni LekaPhiladelphia$734
- Owen MorrisPhiladelphia$554
- Steven SchutzbankPhiladelphia$228
- Glenn TruskinPhiladelphia$169
- Debra SchocherPhiladelphia$127
- Donald MrdjenovichAltoona$26K
- Paul GoehringBeaver Falls$5K
- Carl MattiaYardley$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.